Ribonucleic Acid (RNA) Extraction Machine Market Report 2026

Ribonucleic Acid (RNA) Extraction Machine Market Report 2026 Market Overview

• Ribonucleic Acid (RNA) Extraction Machine Market Report 2026 market size has reached to $1.34 billion in 2025 • Expected to grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.9% • Growth Driver: Rising Infectious Disease Fueling The Growth Of The Market Due To Increasing Urbanization And Disease Transmission • Market Trend: Advanced Automated RNA Extraction Platforms Enhance Laboratory Efficiency And Diagnostic Workflow Automation • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Ribonucleic Acid (RNA) Extraction Machine Market?

A ribonucleic acid (RNA) extraction machine is an automated laboratory instrument designed to isolate and purify RNA from biological samples. It uses specialized reagents and extraction technologies to obtain high-quality RNA for molecular analysis. A ribonucleic acid (RNA) extraction machine improves accuracy, consistency, and efficiency in RNA preparation workflows. The main product types of ribonucleic acid (RNA) extraction machine include manual ribonucleic acid extraction machines and automated ribonucleic acid extraction systems. Manual ribonucleic acid extraction machines refer to systems that require operator involvement to isolate RNA from biological samples through controlled extraction procedures. These machines use technologies such as column based ribonucleic acid extraction and magnetic bead based extraction and support workflows including pre extraction workflow and extraction workflow. The various applications involved are sequencing, polymerase chain reaction testing, gene expression analysis, molecular diagnostics, genomic studies, and others and they are utilized by end users including research laboratories, clinical diagnostics laboratories, biotechnology companies, pharmaceutical development companies, and genomic research institutes.

What Is The Ribonucleic Acid (RNA) Extraction Machine Market Growth Forecast?

The ribonucleic acid (RNA) extraction machine market size is expected to see rapid growth in the next few years. It will grow to $2.27 billion in 2030 at a compound annual growth rate (CAGR) of 10.9%. The growth in the forecast period can be attributed to increasing demand for precision medicine and personalized healthcare solutions, expansion of next generation sequencing based applications, rising automation in laboratory sample preparation workflows, growth of decentralized and point of care diagnostic systems, increasing investments in biotechnology infrastructure and genomic research ecosystems. Major trends in the forecast period include AI integrated automated rna extraction systems enabling high precision and reduced manual errors, fully automated high throughput extraction platforms supporting large scale genomic workflows, magnetic bead based extraction technologies improving yield and purity of nucleic acids, cartridge based closed system extraction machines enhancing contamination free processing, cloud connected laboratory extraction systems enabling remote monitoring and workflow optimization.

What Are The Drivers Of The Ribonucleic Acid (RNA) Extraction Machine Market?

The rising infectious disease is expected to propel the growth of the ribonucleic acid (RNA) extraction machine market going forward. Infectious disease refers to an illness resulting from the invasion and multiplication of harmful microorganisms, including viruses, bacteria, fungi, or parasites, within the body. Infectious disease is rising due to increasing urbanization, as densely populated urban areas accelerate the spread of contagious diseases through close human contact. The RNA extraction machine supports infectious disease by enabling automated RNA isolation, high-throughput sample preparation, and accurate molecular testing workflows. For instance, in May 2026, according to the UK Health Security Agency, a UK-based government agency, between 1 January and 25 May 2026, England recorded 630 laboratory-confirmed measles cases, representing an increase of 88 cases compared with the previous report published on 11 May 2026. Therefore, the rising infectious disease is driving the growth of the ribonucleic acid (RNA) extraction machine industry. The expansion of personalized medicine is expected to propel the growth of the ribonucleic acid (RNA) extraction machine market going forward. Personalized medicine refers to medical treatment approaches tailored to an individual’s genetic, molecular, and biomarker profile to improve therapeutic effectiveness and disease management. Personalized medicine is increasing due to advancements in genomic sequencing technologies, which enable faster and more affordable genetic testing to support targeted therapies and individualized treatment approaches. RNA extraction machines support personalized medicine by isolating high-quality RNA from patient samples, enabling precise gene expression analysis for biomarker identification and targeted treatment selection. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the expansion of personalized medicine is driving the growth of the ribonucleic acid (RNA) extraction machine industry.

Key Players In The Global Ribonucleic Acid (RNA) Extraction Machine Market

Major companies operating in the ribonucleic acid (RNA) extraction machine market report are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Revvity, QIAGEN N.V., Promega Corporation, Analytik Jena GmbH+Co. KG, Bioneer Corporation, Tiangen Biotech (Beijing) Co. Ltd., Hamilton Company, Tecan Group Ltd., Beckman Coulter, LGC Biosearch Technologies

Global Ribonucleic Acid (RNA) Extraction Machine Market Trends and Insights

Major companies operating in the ribonucleic acid (RNA) extraction machine market are focusing on developing advanced automated sample processing platforms to improve nucleic acid purification efficiency, increase throughput, and reduce manual laboratory workload. Automated sample processing platforms are integrated systems that streamline the extraction and purification of RNA and DNA from biological samples with minimal human intervention, ensuring consistent and reliable results. For instance, in January 2023, QIAGEN, a Netherlands-based provider of sample and assay technologies, launched the EZ2 Connect MDx platform for diagnostic laboratories. The automated system enables parallel purification of RNA and DNA from up to 24 samples in as little as 30 minutes using magnetic-bead technology. The platform incorporates prefilled reagent cartridges, onboard pipetting, heating functions, UV decontamination, and digital connectivity features to enhance workflow efficiency, process safety, and laboratory automation for molecular diagnostic applications.

What Defines the Ribonucleic Acid (RNA) Extraction Machine Market?

The ribonucleic acid (RNA) extraction machine market consists of sales of nucleic acid purification cartridges, robotic liquid handling extraction systems, automated sample preparation modules, extraction reagent packs, and high-throughput nucleic acid purification systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, healthcare laboratories, research institutes, and retailers) or directly to end customers. The value of goods in this market includes related software, maintenance, installation, calibration, and technical support services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Ribonucleic Acid (RNA) Extraction Machine Market Report 2026?

The ribonucleic acid (rna) extraction machine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) extraction machine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.